| Year |
Citation |
Score |
| 2023 |
Zhang X, Wang Y, Supekar S, Cao X, Zhou J, Dang J, Chen S, Jenkins L, Marsango S, Li X, Liu G, Milligan G, Feng M, Fan H, Gong W, et al. Pro-phagocytic function and structural basis of GPR84 signaling. Nature Communications. 14: 5706. PMID 37709767 DOI: 10.1038/s41467-023-41201-0 |
0.623 |
|
| 2023 |
Zhang W, Cao X, Zhong X, Wu H, Shi Y, Feng M, Wang YC, Ann D, Gwack Y, Yuan YC, Shang W, Sun Z. SRC2 controls CD4 T cell activation via stimulating c-Myc-mediated upregulation of amino acid transporter . Proceedings of the National Academy of Sciences of the United States of America. 120: e2221352120. PMID 37094160 DOI: 10.1073/pnas.2221352120 |
0.713 |
|
| 2023 |
Zhang X, Wang Y, Supekar S, Cao X, Zhou J, Dang J, Chen S, Jenkins L, Marsango S, Li X, Liu G, Milligan G, Feng M, Fan H, Gong W, et al. Pro-phagocytic function and structural basis of GPR84 signaling. Research Square. PMID 36824923 DOI: 10.21203/rs.3.rs-2535247/v1 |
0.627 |
|
| 2022 |
Zhang W, Cao X, Zhong X, Wu H, Feng M, Gwack Y, Noah I, Sun Z. Steroid nuclear receptor coactivator 2 controls immune tolerance by promoting induced T differentiation via up-regulating Nr4a2. Science Advances. 8: eabn7662. PMID 35704583 DOI: 10.1126/sciadv.abn7662 |
0.702 |
|
| 2022 |
Cao X, Lai SWT, Chen S, Wang S, Feng M. Targeting tumor-associated macrophages for cancer immunotherapy. International Review of Cell and Molecular Biology. 368: 61-108. PMID 35636930 DOI: 10.1016/bs.ircmb.2022.02.002 |
0.631 |
|
| 2022 |
Cao X, Chen J, Li B, Dang J, Zhang W, Zhong X, Wang C, Raoof M, Sun Z, Yu J, Fakih MG, Feng M. Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy. Science Advances. 8: eabl9171. PMID 35302839 DOI: 10.1126/sciadv.abl9171 |
0.718 |
|
| 2022 |
Cao X, Wang Y, Zhang W, Zhong X, Gunes EG, Dang J, Wang J, Epstein AL, Querfeld C, Sun Z, Rosen ST, Feng M. Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced suppression. Blood. PMID 35134139 DOI: 10.1182/blood.2021013901 |
0.729 |
|
| 2021 |
Cao X, Li B, Chen J, Dang J, Chen S, Gunes EG, Xu B, Tian L, Muend S, Raoof M, Querfeld C, Yu J, Rosen ST, Wang Y, Feng M. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer. Journal For Immunotherapy of Cancer. 9. PMID 33753567 DOI: 10.1136/jitc-2020-002022 |
0.624 |
|
| 2020 |
Chen J, Cao X, Li B, Zhao Z, Chen S, Lai SWT, Muend SA, Nossa GK, Wang L, Guo W, Ye J, Lee PP, Feng M. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Frontiers in Immunology. 11: 621757. PMID 33603751 DOI: 10.3389/fimmu.2020.621757 |
0.678 |
|
| 2019 |
Cao X, Zhang W, Moore PK, Bian J. Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity. International Journal of Molecular Sciences. 20. PMID 30646560 DOI: 10.3390/Ijms20020313 |
0.343 |
|
| 2018 |
Cao L, Cao X, Zhou Y, Vijay NB, Wu ZY, Hu LF, Yang Y, Sethi G, Moore PK, Bian JS. Hydrogen sulfide inhibits ATP-induced neuroinflammation and Aβ synthesis by suppressing the activation of STAT3 and cathepsin S. Brain, Behavior, and Immunity. PMID 29981830 DOI: 10.1016/J.Bbi.2018.07.005 |
0.312 |
|
| 2018 |
Cao X, Ding L, Xie ZZ, Yang Y, Whiteman M, Moore PK, Bian JS. A review of hydrogen sulfide synthesis, metabolism and measurement: Is modulation of hydrogen sulfide a novel therapeutic for cancer? Antioxidants & Redox Signaling. PMID 29790379 DOI: 10.1089/Ars.2017.7058 |
0.342 |
|
| 2018 |
Cao X, Nie X, Xiong S, Cao L, Wu Z, Moore PK, Bian JS. Renal protective effect of polysulfide in cisplatin-induced nephrotoxicity. Redox Biology. 15: 513-521. PMID 29413963 DOI: 10.1016/J.Redox.2018.01.012 |
0.402 |
|
| 2017 |
Zhou H, Ding L, Wu Z, Cao X, Zhang Q, Lin L, Bian JS. Hydrogen sulfide reduces RAGE toxicity through inhibition of its dimer formation. Free Radical Biology & Medicine. PMID 28108276 DOI: 10.1016/J.Freeradbiomed.2017.01.026 |
0.328 |
|
| 2016 |
Zhou Y, Wu Z, Cao X, Ding L, Wen Z, Bian JS. HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways. Pharmacological Research. PMID 27507578 DOI: 10.1016/J.Phrs.2016.08.007 |
0.332 |
|
| Show low-probability matches. |